The Commercial Integration Cell is part of the U.S. Space Force's Combined Operations Center, pictured here. (Tech. Sgt Luke Kitterman/U.S. Space Force) The Space Force added five companies to its ...
Elon Musk-led SpaceX has obtained a commercial license from the Federal Communications Commission (FCC) for its Starlink Direct-to-Cell service. This marks a pivotal step in expanding the reach of ...
Kincell Bio, a leading contract development and manufacturing organization (CDMO) supporting autologous and allogeneic cell ...
Officials at Cellares say the Integrated Development and Manufacturing Organization (IDMO) entered multiple strategic technology partnerships to advance the Cell Q™, a fully automated quality control ...
Hosted on MSN
Cryoport outlines $190M–$194M 2026 revenue target as commercial cell therapy drives growth
The company issued full year 2026 revenue guidance of $190 million to $194 million, with Shelton describing this range as "an appropriate starting point for the year." Stefanovich confirmed, "We ...
Register here or on the investor relations page of Actinium's website here. Iomab-ACT is an ARC that targets CD45, a marker expressed on blood cancer cells and immune cells that is intended to enable ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results